REVLON INC-CLASS A (REV)

US7615256093 - Common Stock

3.8999  -0.22 (-5.34%)

Fundamental Rating

2

Taking everything into account, REV scores 2 out of 10 in our fundamental rating. REV was compared to 37 industry peers in the Personal Care Products industry. While REV seems to be doing ok healthwise, there are quite some concerns on its profitability. REV is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year REV has reported negative net income.
REV had a negative operating cash flow in the past year.
REV had negative earnings in each of the past 5 years.
In the past 5 years REV always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -15.41%
ROE N/A
ROIC 8.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of REV has declined.
Industry RankSector Rank
OM 8.37%
PM (TTM) -18.74%
GM N/A
OM growth 3YN/A
OM growth 5Y-8.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

REV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
REV has more shares outstanding than it did 1 year ago.
The debt/assets ratio for REV is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.60, we must say that REV is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for REV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.6
ROIC/WACC1.16
WACC7.62%

2.3 Liquidity

A Current Ratio of 1.23 indicates that REV should not have too much problems paying its short term obligations.
A Quick Ratio of 0.75 indicates that REV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.75

2

3. Growth

3.1 Past

The earnings per share for REV have decreased strongly by -124.11% in the last year.
REV shows a small growth in Revenue. In the last year, the Revenue has grown by 0.61%.
REV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.29% yearly.
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-308.91%
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y-2.29%
Revenue growth Q2Q-11.02%

3.2 Future

The Earnings Per Share is expected to decrease by -7.58% on average over the next years.
Based on estimates for the next years, REV will show a small growth in Revenue. The Revenue will grow by 4.04% on average per year.
EPS Next Y-39.42%
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%
EPS Next 5Y-7.58%
Revenue Next Year3.47%
Revenue Next 2Y4.29%
Revenue Next 3Y3.95%
Revenue Next 5Y4.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.77

4.3 Compensation for Growth

A cheap valuation may be justified as REV's earnings are expected to decrease with -11.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%

0

5. Dividend

5.1 Amount

No dividends for REV!.
Industry RankSector Rank
Dividend Yield N/A

REVLON INC-CLASS A

NYSE:REV (10/20/2022, 7:11:10 PM)

3.8999

-0.22 (-5.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap228.40M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 8.37%
PM (TTM) -18.74%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.23
Quick Ratio 0.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-39.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y